Companies › Oticara Australia
1 active drug program in 11 registered trials: 8 Phase 4, 2 Phase 3, 1 Phase 2; Neurology, Infectious disease, Oncology, Other.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Betamethasone Glucocorticoid receptor agonist | NR3C1 | Phase 2 | Chronic Rhinosinusitis (Diagnosis); Hemiplegia; Myofascial Pain Dysfunction Syndrome; Anaphylactic Reaction … | – |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT05260125 | Betamethasone | Phase 4 | Hemiplegia | Neurology | Mar 2025 |
| NCT05882903 | Betamethasone | Phase 2 | Chronic Rhinosinusitis (Diagnosis) | Respiratory | Jun 2025 |
| NCT06915857 | Betamethasone | Phase 3 | Breast Cancer | Oncology | Dec 2026 |
| NCT07547605 | Betamethasone | Phase 4 | Myofascial Pain Dysfunction Syndrome | Other | Dec 2026 |
| NCT07341776 | Betamethasone | Phase 4 | Anaphylactic Reaction | Other | Dec 2026 |
| NCT05114096 | Betamethasone | Phase 4 | Preterm Birth | Other | Dec 2026 |
| NCT07508124 | Betamethasone | Phase 4 | Urinary Tract Infection | Infectious disease | Dec 2027 |
| NCT07692516 | Betamethasone | Phase 4 | Subacromial Impingement Syndrome | Neurology | Dec 2027 |
| NCT06527235 | Betamethasone | Phase 3 | Meniscus Lesion | Other | Jun 2028 |
| NCT07416916 | Betamethasone | Phase 4 | Frozen Shoulder | Other | Oct 2030 |
| NCT07416916 | Betamethasone | Phase 4 | Frozen Shoulder | Other | Oct 2030 |
Optinose US Santhera Pharmaceuticals Corcept Therapeutics Alimera Sciences Guangzhou Novaken Pharm
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.